Entourage Health Corp.
ETRGFOTCHealthcare
$0.00
+$0.00(+14.29%)
Market Cap$1233548
P/E Ratio—
52W High$0.0148
52W Low$0.0029
Entourage Health Corp. (ETRGF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ETRGF · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2024Report Date: Nov 25, 2024EPS Actual
-$0.02
Revenue
$0.01B
Fiscal Period
Q4 FY2024
FY ends December
Report Date
Nov 25, 2024
After Market Close
ETRGF reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2025 | Aug 25, 2025 | — | — | — | — | — | — |
| ◌ Q2 FY2025 | Apr 28, 2025 | — | — | — | — | — | — |
| ◌ Q1 FY2025 | Feb 26, 2025 | — | — | — | — | — | — |
| — Q4 FY2024 | Nov 25, 2024 | — | -$0.02 | — | $0.01B | — | — |
| — Q3 FY2024 | Aug 27, 2024 | — | -$0.02 | — | $0.01B | — | — |
| — Q2 FY2024 | May 28, 2024 | — | -$0.02 | — | $0.01B | — | — |
| — Q2 FY2024 | Apr 30, 2024 | — | -$0.04 | — | $0.01B | — | — |
| — Q4 FY2023 | Nov 28, 2023 | — | -$0.02 | — | $0.01B | — | — |
Q3 FY2025
Aug 25, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
Apr 28, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Feb 26, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Nov 25, 2024
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q3 FY2024
Aug 27, 2024
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q2 FY2024
May 28, 2024
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q2 FY2024
Apr 30, 2024
EPS Actual
-$0.04
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q4 FY2023
Nov 28, 2023
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2022 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2022 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2022 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2021 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2021 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2021 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2022 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2022 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2022 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2021 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2021 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2021 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q4 FY2024 | Nov 25, 2024 | — | $0.01 | $0.00 | -42.08% |
| — Q3 FY2024 | Aug 27, 2024 | — | $0.01 | $0.01 | +0.00% |
| — Q2 FY2024 | May 28, 2024 | — | $0.01 | $0.01 | -0.91% |
| — Q2 FY2024 | Apr 30, 2024 | — | $0.01 | $0.01 | +24.24% |
| — Q4 FY2023 | Nov 28, 2023 | — | $0.01 | $0.01 | -11.18% |
| — Q3 FY2023 | Aug 29, 2023 | — | $0.01 | $0.01 | +13.39% |
| — Q2 FY2023 | May 30, 2023 | — | $0.01 | $0.02 | +17.76% |
| — Q2 FY2023 | Apr 28, 2023 | — | $0.02 | $0.02 | +3.28% |
Q4 FY2024-42.08%
Report Date
Nov 25, 2024
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.00
Q3 FY2024+0.00%
Report Date
Aug 27, 2024
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q2 FY2024-0.91%
Report Date
May 28, 2024
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q2 FY2024+24.24%
Report Date
Apr 30, 2024
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q4 FY2023-11.18%
Report Date
Nov 28, 2023
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q3 FY2023+13.39%
Report Date
Aug 29, 2023
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q2 FY2023+17.76%
Report Date
May 30, 2023
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.02
Q2 FY2023+3.28%
Report Date
Apr 28, 2023
EPS Beat/Miss
—
Price Before
$0.02
Price After
$0.02
Beat Rate0 / 8 quarters
Largest Move-42.08% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ETRGF ends December
Entourage Health Corp. (ETRGF) most recently reported earnings on November 25, 2024 for Q4 FY2024, posting EPS of $-0.02 (in line with the analyst consensus of —). The next ETRGF earnings date is expected around September 1, 2026.
Each quarter, investors track ETRGF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ETRGF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ETRGF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ETRGF earnings · 4 questionsEntourage Health Corp.'s next earnings report is expected around September 1, 2026. ETRGF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ETRGF historically reports after market close (AMC).
ETRGF earnings datewhen is ETRGF earningsETRGF next earnings datewhen does ETRGF report earningsETRGF earnings calendar
▸ Source: FMP · Entourage Health Corp. SEC filings · US GAAP · Entourage Health Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026